NSF/FDA SIR: The Role of Microbial Growth on Breast Implant Complications: Integration of Surface Properties, Extractable By-Product, and Biofilm Modeling
NSF/FDA SIR: The Role of Microbial Growth on Breast Implant Complications: Integration of Surface Properties, Extractable By-Product, and Biofilm Modeling
批准号:
2129311
负责人:
Stephen Arhin
金额:
$9.99万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-10-01 至 2023-09-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Both the Food and Drug Administration (FDA) and the World Health Organization have identified a rare type of non-Hodgkin’s lymphoma associated with breast implants. FDA data indicate that textured implants are more likely to develop this type of complication. The link is strong enough that the FDA issued a voluntary recall of some textured breast implants (Class I recall). However, the mechanism between how textured implants may trigger this rare non-Hodgkin’s lymphoma is unknown. Thus, the goal of this NSF/FDA Scholar in Residence project is to better understand how these textured surfaces are distinct from smooth surfaces, which may help medical device makers and regulators prevent complications from cosmetic and other types of implants. The project will support the interdisciplinary training of a post-doctoral researcher at Howard University. Additional activities associated with this research include an event at Howard University with experts from various federal and local regulatory agencies to discuss how interdisciplinary science is needed for regulatory activities, standards development, and opportunities for graduate students to work in government agencies after graduation. The goal of this project is to assess how surface properties and particles that are shed from breast implants impact biofilm formation. Evidence of a link between BIA-ALCL (breast implant-associated anaplastic large cell lymphoma) and textured implants was conclusive enough to have recently triggered a series of regulatory actions worldwide. The work is motived by studies that have shown that these textured breast implants shed particles, which has led to the central hypothesis that the surface physicochemical properties such as extractables and particle shedding on breast implants influence biofilm formation. The investigators will employ experimental systems and computational models to test this hypothesis with two objectives. First, a biofilm reactor system will be used to evaluate biofilm formation rates on surfaces with various physiochemical properties, e.g., porosity, how surface features affect particle distribution, and the level of bacterial adhesion and biofilm formation on surfaces with and without particles. Second, a computational model (COMSOL) will to be used to evaluate the effects of surface properties and extractables. A sensitivity analysis will be conducted to determine which model parameters drive the results, including biofilm detachment parameters, Monod kinetic growth parameters, and particle transport parameters. Following sensitivity analysis, the parameters of interest will be calibrated using experimental results obtained in the first objective. Finally, the model will be evaluated using a different experimental condition (different surface roughness) to assess the predictive capability of the model. Information garnered from this project will advance regulatory science by providing a more mechanistic explanation for biofilm growth that may contribute to BIA-ALCL.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
FDA上市药物库筛选鉴定靶向治疗ARID1A缺陷型结直肠癌的合成致死效应及分子机制研究
-
批准号:82373165
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:李爱民
-
依托单位:
多维互质结构FDA雷达稀疏空时距自适应处理研究
-
批准号:61771317
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2017
-
负责人:阳召成
-
依托单位:
基于FDA标记畸胎瘤细胞联合人胎盘屏障体外模型建立中药胚胎毒性评价体系的研究
-
批准号:81573740
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2015
-
负责人:宋殿荣
-
依托单位: